–
Kymera Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−208
FY23:
−244
FY24:
−309
FY25:
−389
(positive)
Change from FY21 to FY23
millions USD
FY21:
−97.6
FY22:
−152
FY23:
−143
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−100
FY22:
−155
FY23:
−147
FY24:
–
FY25:
−311
(positive)
Change from FY21 to FY25
millions USD
FY21:
−100
FY22:
−155
FY23:
−147
FY24:
−224
FY25:
−311
All amounts in millions USD